TRABID, or TRAF-binding domain, is an enzyme that belongs to the family of deubiquitinating enzymes (DUBs). Ubiquitination, the process of adding ubiquitin molecules to proteins, is a post-translational modification that can dictate various fates for a protein, including its degradation, localization, or activity. Deubiquitinating enzymes, like TRABID, counteract this process by removing ubiquitin moieties, thus playing a critical role in maintaining cellular protein homeostasis and regulating protein functions. TRABID specifically recognizes and cleaves the K63-linked polyubiquitin chains, which are often associated with signaling pathways rather than protein degradation. This selectivity underlines the role of TRABID in fine-tuning cellular signaling cascades.
TRABID Activators are a group of chemical compounds that enhance the activity of the TRABID enzyme. By increasing the activity of TRABID, these activators can potentially influence the balance of ubiquitination and deubiquitination within the cell, particularly regarding proteins modified with K63-linked polyubiquitin chains. As a result, cellular processes and signaling pathways regulated by K63-linked ubiquitination might be affected by the presence and activity of these activators. Given the pivotal role of ubiquitination in modulating protein function and signaling, TRABID activators present an intriguing tool to study these cellular dynamics. Their ability to modulate the ubiquitination state of proteins can help elucidate the nuanced roles of ubiquitination in cellular processes and how imbalances in this system can impact cellular health and function.
SEE ALSO...
Items 81 to 11 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|